Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045182 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-02 | 2021-07-01 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $85.24 | -55.5K | 160.8K | -26% | -$4.73M |
| DM | 2021-07-02 | 2021-07-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $5.64 | +55.5K | 163.6K | +51% | +$313.2K |
| DM | 2021-07-02 | 2021-07-01 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $0.00 | -55.5K | 22.3K | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | S | D | 100 | $84.83 | 163,482 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-01 | S | D | 707 | $90.30 | 161,030 | D | — | — | (F6) Represents the weighted average sale price of the shares sold ranging from $89.78 to $90.68 per share. |
| 3 | Common | Common Stock | 2021-07-01 | M | A | 27,685 | $4.89 | 148,199 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-01 | M | A | 6,932 | $4.84 | 120,514 | D | — | — | |
| 5 | Common | Common Stock | 2021-07-01 | M | A | 5,534 | $7.87 | 113,582 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-01 | S | D | 400 | $88.93 | 161,737 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $88.65 to $89.48 per share. |
| 7 | Common | Common Stock | 2021-07-01 | S | D | 50,000 | $84.56 | 108,048 | D | — | — | |
| 8 | Common | Common Stock | 2021-07-01 | S | D | 1,145 | $87.90 | 162,137 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $87.50 to $88.28 per share. |
| 9 | Common | Common Stock | 2021-07-01 | S | D | 200 | $86.56 | 163,282 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $86.47 to $86.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 3 through 10. |
| 10 | Common | Common Stock | 2021-07-01 | S | D | 100 | $95.30 | 158,048 | D | — | — | |
| 11 | Common | Common Stock | 2021-07-01 | S | D | 1,825 | $94.63 | 158,148 | D | — | — | (F10) Represents the weighted average sale price of the shares sold ranging from $94.22 to $95.12 per share. |
| 12 | Common | Common Stock | 2021-07-01 | S | D | 400 | $93.31 | 159,973 | D | — | — | (F9) Represents the weighted average sale price of the shares sold ranging from $93.21 to $93.54 per share. |
| 13 | Common | Common Stock | 2021-07-01 | S | D | 432 | $92.26 | 160,373 | D | — | — | (F8) Represents the weighted average sale price of the shares sold ranging from $91.88 to $92.41 per share. |
| 14 | Common | Common Stock | 2021-07-01 | S | D | 225 | $91.06 | 160,805 | D | — | — | (F7) Represents the weighted average sale price of the shares sold ranging from $90.81 to $91.64 per share. |
| 15 | Common | Common Stock | 2021-07-01 | M | A | 15,383 | $6.55 | 163,582 | D | — | — | |
| 16 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | M | D | 15,383 | $0.00 | 166,643 | D | $6.55 · — to 2028-01-16 | 15,383 Common Stock | (F11) This option is fully vested. |
| 17 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | M | D | 6,932 | $0.00 | 27,628 | D | $4.84 · — to 2025-01-05 | 6,932 Common Stock | (F11) This option is fully vested. |
| 18 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | M | D | 5,534 | $0.00 | 0 | D | $7.87 · — to 2023-08-12 | 5,534 Common Stock | (F11) This option is fully vested. |
| 19 | Derivative | Stock Option (Right to Buy) | 2021-07-01 | M | D | 27,685 | $0.00 | 22,315 | D | $4.89 · — to 2025-10-15 | 27,685 Common Stock | (F11) This option is fully vested. |